Scott David Swanson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 795 Columbia River Hwy, St. Helens, OR 97051 Phone: 503-397-0662 Fax: 503-397-0753 |
News Archive
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Despite the coronavirus infection numbers skyrocketing, there is still good news. A team of scientists found that the novel coronavirus is not mutating significantly, suggesting any vaccine developed to fight SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) would remain effective in the long term.
Today sees the launch of Global Research Nurses, a new interactive network which allows nurses around the world to become a leading voice in global health research.
Universal Detection Technology (www.udetection.com), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, responded today to a bipartisan congressional committee's scathing report card failing the U.S. Government for adequately preparing the country for the threat of a bioterrorism attack.
› Verified 1 days ago